Fapon Biotech Inc., (Fapon), founded in 2001, is a global leading IVD reagent raw materials and one-stop solutions provider. In the past 17 years, Fapon had edged out many foreign brands through its self-developed products and rewarded exceptional growth. Today, Fapon not only has greatest market share in China, but also has more than 700 customers globally, crossing over North America, Europe, Asia Pacific and the Middle East for shaping the world a better healthcare environment.
Fapon possesses a series of cutting-edge platforms and an extensive IVD raw materials portfolio. These world-class level technology platforms include Chemiluminescence, Elisa, Fluorescence POCT, Fluorescent Real-time PCR, Gene Sequencing, Immunological Turbidimetry, etc. To highlight, Fapon is the largest IVD raw material supplier in the Asian market with more than 700 available raw material covering antigen, antibody and diagnostic enzyme that could be applied widely in platforms CLIA, Rapid Diagnosis, Molecular Diagnosis, Clinical Biochemistry, etc.
Fapon is committed to providing product and service innovations to customers with no mid- and downstream market participation. Building on 17 years industry experience and deep insights of market trends, Fapon has launched a series of innovative total solutions to achieve customer needs of different application scenarios that include Chemiluminescence Immunoassay, POCT Immunofluorescence, Immunoturbidimetric Reagent Development, etc. Fapon is further diversifying the one-stop solution portfolio to offer more business opportunities to our customers.
Visit Fapon at Booth H3-A81 and http://en.fapon.com/ for more information.